Non-alcoholic fatty liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue SUPPL. 1, 2002, Pages

  Angulo, Paul ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; BETAINE; DIMETAMFETAMINE; GEMFIBROZIL; URSODEOXYCHOLIC ACID;

CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE COURSE; DRUG MECHANISM; FATTY LIVER; HEPATITIS; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; METABOLIC REGULATION; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS; STEATOSIS; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 0036103602     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.17.s1.10.x     Document Type: Conference Paper

References (43)

1. Non-alcoholic steatohepatitis. Mayo Clinic experience with a hitherto unnamed disease
2. Non-alcoholic fatty liver disease
3. Non-alcoholic steatohepatitis: Another disease of affluence
4. Prevalence of and risk factors for hepatic steatosis in northern Italy
5. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
6. Liver pathology in morbidly obese patients with and without diabetes
7. Body fat topography as an independent predictor of fatty liver
8. Prevalence of fatty liver in a general population of Okinawa
9. Liver abnormalities in severely obese subjects. Effect of drastic weight loss after gastroplasty
10. Prevalence of fatty liver in Japanese children and relationship to obesity
11. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis
12. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population
13. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients
14. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients
15. Serum alanine aminotransferase levels among volunteer blood donors: Effect of sex, alcohol intake and obesity
16. Cryptogenic cirrhosis. Clinical characterization and risk factors for underlying disease
17. The ratio of aspartate aminotransferase to alanine aminotransferase: Potential value in differentiating non-alcoholic steatohepatitis from alcoholic liver disease
18. Fatty liver hepatitis and cirrhosis in obese patients
19. Alcohol-like liver disease in non-alcoholics
20. Non-alcoholic steatohepatitis. A study of 49 patients
21. The natural history of non-alcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
22. Non-alcoholic steatohepatitis: An expanded clinical entity
23. The natural history of non-alcoholic fatty liver: A follow-up study
24. Non-alcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
25. Liver fibrosis in overweight patients
26. Non-alcoholic fatty liver disease. A spectrum of clinical and pathological severity
27. Insulin resistance and mitochondrial abnormalities in NASH. A cool look into a burning issue
28. Association of non-alcoholic fatty liver disease with insulin resistance
29. Non-alcoholic steatohepatitis. Association of insulin resistance and mitochondrial abnormalities
30. Steatohepatitis. A tale of two 'hits'?
31. Mitochondria in steatohepatitis
32. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?
33. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients
34. Hepatic effect of dietary weight loss in morbidly obese patients
35. Effect of weight reduction on hepatic abnormalities in overweight patients
36. Non-alcoholic steatohepatitis in obesity: A reversible condition
37. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
38. Non-alcoholic steatohepatitis in children
39. A persistent aminotransferasemia resolving after weight reduction of children
40. Liver morphology and function tests in obesity and during total starvation
41. Treatment of non-alcoholic fatty liver: Present and emerging therapies
42. Recurrence of non-alcoholic steatohepatitis following liver transplantation
43. Development of non-alcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis